These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1450446)

  • 1. Antiproliferative effect of complexes of platinum (II) with plasmanyl-(N-acyl)-ethanolamine, an inhibitor of protein kinase C.
    Mikhaevich IS; Vlasenkova NK; Gerasimova GK
    Anticancer Drugs; 1992 Oct; 3(5):513-7. PubMed ID: 1450446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antiproliferative effect of cis-diammine-dichloroplatinum (II) and a new anticancer agent, plasmanyl-(N-acyl)-ethanolamine, an inhibitor of protein kinase C.
    Mikhaevich IS; Vlasenkova NK; Gerasimova GK
    Biomed Sci; 1991; 2(6):659-64. PubMed ID: 1841636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New tumoricidal semisynthetic ether phospholipid, plasmanyl-(N-acyl)ethanolamine (PNAE(s)) and enhancement of its tumoricidal activity by calcium ions.
    Kára J; Konovalova AL; Krasnova MA; Liebl V; Bejsovcová L
    Neoplasma; 1993; 40(4):213-7. PubMed ID: 8272147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin.
    Agudo-López A; Prieto-García E; Alemán J; Pérez C; Díaz-García CV; Parrilla-Rubio L; Cabrera S; Navarro-Ranninger C; Cortés-Funes H; López-Martín JA; Agulló-Ortuño MT
    Mol Cancer; 2017 Feb; 16(1):45. PubMed ID: 28231799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of anti-tumor agents cisplatin and cycloplatam on membrane protein kinase C activity in murine T-lymphocytes].
    Khabarov SV; Gerasimova GK
    Biokhimiia; 1996 Oct; 61(10):1866-73. PubMed ID: 9011234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
    O'Neill CF; Hunakova L; Kelland LR
    Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR
    Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nontoxic alkyl-phospholipid with selective antitumor activity, plasmanyl-(N-acyl)-ethanolamine (PNAE), isolated from degenerating chick embryonal tissues and from an anticancer biopreparation cACPL.
    Kára J; Borovicka M; Liebl V; Smolíková J; Ubik K
    Neoplasma; 1986; 33(2):187-205. PubMed ID: 3713923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of a new antitumor semisynthetic ether phospholipid, 14C-labeled plasmanyl-(N-acyl)ethanolamine, in mice bearing sarcoma Mc11.
    Kára J; Zimakova NI; Serebryakova EA; Dĕdková V; Zolotaryov AE
    J Cancer Res Clin Oncol; 1994; 120(11):662-7. PubMed ID: 7962042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines.
    Mellish KJ; Barnard CF; Murrer BA; Kelland LR
    Int J Cancer; 1995 Sep; 62(6):717-23. PubMed ID: 7558420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The new antitumor drug cycloplatam: cytotoxicity and DNA interstrand cross-linking].
    Gorbacheva LB; Vasil'eva SV; Makhova EV; Moshkovskaia EIu; Sokolova IS; Tikhomirov AG; Dederer LIu
    Antibiot Khimioter; 1999; 44(4):9-12. PubMed ID: 10483489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of the synergistic interaction between 2'-deoxy-5-azacytidine and cisplatin.
    Abbruzzese JL; Frost P
    Cancer Chemother Pharmacol; 1992; 30(1):31-6. PubMed ID: 1375133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
    Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
    Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
    Arzuman L; Beale P; Yu JQ; Proschogo N; Huq F
    Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro.
    McKeage MJ; Abel G; Kelland LR; Harrap KR
    Br J Cancer; 1994 Jan; 69(1):1-7. PubMed ID: 8286188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin is active in vitro against human melanoma cell lines: comparison with cisplatin and carboplatin.
    Mohammed MQ; Retsas S
    Anticancer Drugs; 2000 Nov; 11(10):859-63. PubMed ID: 11142694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands.
    Coluccia M; Nassi A; Boccarelli A; Giordano D; Cardellicchio N; Locker D; Leng M; Sivo M; Intini FP; Natile G
    J Inorg Biochem; 1999 Oct; 77(1-2):31-5. PubMed ID: 10626350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antileukemic activity and development of resistance to cisplatin (CPT) and platinum (IV)-nitroxyl complex VS118].
    Goncharova SA; Raevskaia TA; Iakushchenko TN; Blokhina SV; Konovalova NP; Sen' VD
    Vopr Onkol; 2011; 57(3):355-8. PubMed ID: 21882607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity, DNA strand breakage and DNA-protein crosslinking by a novel transplatinum compound in human A2780 ovarian and MCF-7 breast carcinoma cells.
    Farrell N; Povirk LF; Dange Y; DeMasters G; Gupta MS; Kohlhagen G; Khan QA; Pommier Y; Gewirtz DA
    Biochem Pharmacol; 2004 Sep; 68(5):857-66. PubMed ID: 15294448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells.
    Perego P; Gatti L; Caserini C; Supino R; Colangelo D; Leone R; Spinelli S; Farrell N; Zunino F
    J Inorg Biochem; 1999 Oct; 77(1-2):59-64. PubMed ID: 10626355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.